Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF

被引:64
作者
Man, Xiao-Yong [1 ]
Yang, Xiao-Hong [1 ]
Cai, Sui-Qing [1 ]
Bu, Zhang-Yu [1 ]
Zheng, Min [1 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Dermatol, Hangzhou 310009, Zhejiang, Peoples R China
关键词
psoriasis; keratinocyte; VEGFR; VEGF; calcium;
D O I
10.1111/j.1582-4934.2007.00112.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Psoriasis is a common chronic inflammatory disease of the skin characterized by epidermal hyperplasia and angiogenesis. Recently, vascular endothelial growth factor receptors (VEGFRs, including VEGFR-1, VEGFR-2 and VEGFR-3) were found to be expressed in normal human epidermis and associated with proliferation and migration of keratinocytes. The purpose of this study is to investigate the expression of VEGFRs on psoriatic keratinocytes and the roles of calcium and VEGF in regulating VEGFR expression. Skin samples from 17 patients with chronic plaque psoriasis and 11 normal controls were included. The expression of VEGFRs in psoriatic keratinocytes at mRNA and protein levels was determined by reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blot analysis. Localization of the VEGFRs in skin lesions was determined by immuno-fluorescent method. Since keratinocyte proliferation and differentiation rely on calcium concentrations, and VEGF is overexpressed in psoriatic epidermis, we further investigated the roles of calcium and VEGF in regulating the expression of VEGFRs. Overexpression of VEGFR-1, VEGFR-2 and VEGFR-3 in psoriatic epidermis was demonstrated both at mRNA and protein levels in vitro. VEGFRs were strongly labeled in non-lesional, perilesional and lesional psoriatic keratinocytes in all viable epidermal stratums in vivo. Furthermore, both exogenous VEGF165 and calcium enhanced the expression of VEGFRs. Calcium also enhanced the expression of VEGF in non-lesional psoriatic keratinocytes, while targeted blockade of VEGF activity by bevacizum-ab could not inhibit calcium-induced up-regulation of protein levels of VEGFRs. We conclude from these results that VEGFRs are overexpressed in lesional psoriatic epidermal keratinocytes. Both calcium and VEGF regulate VEGFRs expression in psoriatic epidermis. More importantly, calcium is a potential regulator for VEGFR independent of VEGF.
引用
收藏
页码:649 / 660
页数:12
相关论文
共 39 条
[1]   Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis [J].
Bhushan, M ;
McLaughlin, B ;
Weiss, JB ;
Griffiths, CEM .
BRITISH JOURNAL OF DERMATOLOGY, 1999, 141 (06) :1054-1060
[2]   Changes in calcium responsiveness and handling during keratinocyte differentiation - Potential role of the calcium receptor [J].
Bikle, DD ;
Ratnam, A ;
Mauro, T ;
Harris, J ;
Pillai, S .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (04) :1085-1093
[3]   Getting under the skin: The immunogenetics of psoriasis [J].
Bowcock, AM ;
Krueger, JG .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (09) :699-711
[4]  
Boyce S.T., 1983, J INVEST DERMATOL S, V81, P33
[5]  
BROWN LF, 1993, AM J PATHOL, V143, P1255
[6]  
BRUNO M, 2006, EXP DERMATOL, V15, P469
[7]   VEGF inhibitors in cancer therapy [J].
Cardones, AR ;
Bañez, LL .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (03) :387-394
[8]   Evidence for vascular endothelial growth factor (VEGF) as a modifier gene in psoriasis [J].
Detmar, M .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (01) :XIV-XV
[9]   OVEREXPRESSION OF VASCULAR-PERMEABILITY FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR AND ITS RECEPTORS IN PSORIASIS [J].
DETMAR, M ;
BROWN, LF ;
CLAFFEY, KP ;
YEE, KT ;
KOCHER, O ;
JACKMAN, RW ;
BERSE, B ;
DVORAK, HF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) :1141-1146
[10]   Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice [J].
Detmar, M ;
Brown, LF ;
Schön, MP ;
Elicker, BM ;
Velasco, P ;
Richard, L ;
Fukumura, D ;
Monsky, W ;
Claffey, KP ;
Jain, RK .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (01) :1-6